Combination therapy Clinical Trials
4 recruitingDrug
Phase 43
Showing 1–4 of 4 trials
Recruiting
Phase 4
Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)
Group 2 Pulmonary HypertensionHFpEFHFmrEF+2 more
Gachon University Gil Medical Center64 enrolled15 locationsNCT07147114
Recruiting
Phase 4
Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
Coronary Artery DiseasePlaque, AtheroscleroticAtherosclerosis of Coronary Artery
Korea University Anam Hospital408 enrolled1 locationNCT06767345
Recruiting
Phase 4
Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus
DiabetesASCVDStatin
Korea University Anam Hospital2,000 enrolled1 locationNCT06767774
Recruiting
A single-arm, open-label, multi-centre pilot study evaluating the efficacy and safety of Ro 25-8310 combination therapy with Ro 20-9963 in pateints with chronic hepatitis C attending a methdone clinic
Melbourne Health50 enrolled1 locationACTRN12605000682640